JP Morgan and RBS came out today with buys on the stock with 70c as a price target. Credit Suisse has a buy with a price target upgraded from 55c to 76c
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025